- Home
- DGLY vs BDRX Comparison
DGLY vs BDRX Comparison
Compare DGLY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- BDRX
- Stock Information
- Founded
- DGLY 2004
- BDRX 2000
- Country
- DGLY United States
- BDRX United Kingdom
- Employees
- DGLY N/A
- BDRX N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- BDRX Health Care
- Exchange
- DGLY Nasdaq
- BDRX Nasdaq
- Market Cap
- DGLY 4.2M
- BDRX 3.6M
- IPO Year
- DGLY N/A
- BDRX N/A
- Fundamental
- Price
- DGLY $2.47
- BDRX $1.15
- Analyst Decision
- DGLY
- BDRX
- Analyst Count
- DGLY 0
- BDRX 0
- Target Price
- DGLY N/A
- BDRX N/A
- AVG Volume (30 Days)
- DGLY 1.3M
- BDRX 3.6M
- Earning Date
- DGLY 05-21-2025
- BDRX 04-11-2025
- Dividend Yield
- DGLY N/A
- BDRX N/A
- EPS Growth
- DGLY N/A
- BDRX N/A
- EPS
- DGLY N/A
- BDRX N/A
- Revenue
- DGLY $18,596,715.00
- BDRX N/A
- Revenue This Year
- DGLY N/A
- BDRX N/A
- Revenue Next Year
- DGLY N/A
- BDRX N/A
- P/E Ratio
- DGLY N/A
- BDRX N/A
- Revenue Growth
- DGLY N/A
- BDRX N/A
- 52 Week Low
- DGLY $1.93
- BDRX $1.01
- 52 Week High
- DGLY $320.00
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- DGLY 23.18
- BDRX 39.66
- Support Level
- DGLY $2.23
- BDRX $1.01
- Resistance Level
- DGLY $2.73
- BDRX $1.26
- Average True Range (ATR)
- DGLY 0.59
- BDRX 0.12
- MACD
- DGLY 3.20
- BDRX 0.01
- Stochastic Oscillator
- DGLY 16.17
- BDRX 15.22
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.